Keywords: AstraZeneca, Seroquel, EU approval, Bipolar disorder
AstraZeneca’s Seroquel gets EU approval for bipolar recurrence
Article | 30 September 2009
AstraZeneca says that its once-daily Serooquel XR (quetiapine fumarate extended-release tablets) and Seroquel have been approved under the European Mutual ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- UK's NICE does U-turn, recommending Zytiga as Janssen cuts price
- ABPI chief asks: Is saving money more important than saving lives?
- Ambitious growth targets set for Bayer Healthcare in 2014
- GlaxoSmithKline buys full control of Cellzome
- Ophthalmic drugs market set for $18.7 billion value in 2012, says Visiongain
